Posted By John Morris On 26 Dec 2025 Comments (13)
Nitrosamine contamination in generic drugs has triggered dozens of recalls since 2018. Learn which medications were affected, how these carcinogenic impurities form, and how the FDA's response has evolved to balance safety with supply stability.
READ MORE
Posted By John Morris On 25 Dec 2025 Comments (12)
Generics keep global healthcare spending in check by cutting drug prices by up to 95%. They’re essential in high-income countries and life-saving in low-income ones, but adoption varies widely due to policy, access, and innovation.
READ MORE
Posted By John Morris On 23 Dec 2025 Comments (11)
Recent contamination cases in generic drugs-including NDMA in valsartan and benzene in Mucinex-reveal serious safety gaps. Learn how these failures happen, which drugs are at risk, and what you can do to protect yourself.
READ MORE
Posted By John Morris On 19 Dec 2025 Comments (15)
Learn when to give fever reducers after your child's vaccines. Find out why waiting 4 hours matters, which vaccines need special care, and how to safely manage fever without harming immunity.
READ MORE
Posted By John Morris On 15 Dec 2025 Comments (8)
The FDA's Pregnancy and Lactation Labeling Rule (PLLR) replaced outdated letter categories with detailed, evidence-based drug safety info for pregnant and breastfeeding women. Learn how to read the new labels and make safer choices.
READ MORE
Posted By John Morris On 15 Dec 2025 Comments (9)
Combining ADHD stimulants with MAOIs can cause a life-threatening hypertensive crisis. Learn why this drug interaction is dangerous, which medications carry the highest risk, and what safer alternatives exist.
READ MORE
Posted By John Morris On 12 Dec 2025 Comments (10)
Specialists often choose brand-name specialty drugs over cheaper biosimilars due to clinical uncertainty, administrative burdens, hidden pricing practices, and patient pressure-despite evidence showing alternatives work just as well.
READ MORE
Posted By John Morris On 10 Dec 2025 Comments (12)
Lot-to-lot variability is a natural part of biologics and biosimilars due to their complex production in living cells. Unlike generics, biosimilars aren't identical copies - but they're proven safe and effective despite natural batch differences.
READ MORE
Posted By John Morris On 2 Dec 2025 Comments (9)
Replicate study designs are essential for accurately assessing bioequivalence of highly variable drugs. Learn how TRT/RTR and TRRT/RTRT designs reduce sample sizes, meet regulatory standards, and improve generic drug safety.
READ MORE
Posted By John Morris On 1 Dec 2025 Comments (9)
Medical societies have conflicting stances on generic drug substitution. While most generics are safe, neurologists and other specialists warn against switching certain high-risk medications due to potential safety risks. Here's what doctors really think.
READ MORE